Gilead's COVID-19 drug remdesivir seemingly failed to produce an effect according to results of a Chinese clinical trial posted inadvertently on the World Health Organizatio
Research into drugs that could treat or prevent COVID-19 continued full steam ahead this week as the industry puts all its resources into fighting the coronavirus pandemic.
As the search for therapies for COVID-19 continues, European regulators have urged caution over the cardiac side-effects of chloroquine and its close relative hydroxychloroquine.
